Hedge Fund - Palo Alto Investors
Revance Therapeutics Inc. (RVNC)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $0 | 0% | 0 | $4.36 |
| 2 | 2024 - Q3 (2024-09-30) | $8,365,175 | 1.08% | 1,611,787 | $4.97 |
| 3 | 2024 - Q2 (2024-06-30) | $13,510,711 | 1.56% | 5,257,086 | $3.41 |
| 4 | 2024 - Q1 (2024-03-31) | $25,820,180 | 2.91% | 5,248,004 | $5.92 |
| 5 | 2023 - Q4 (2023-12-31) | $46,035,726 | 4.14% | 5,237,284 | $8.19 |
| 6 | 2023 - Q3 (2023-09-30) | $59,972,145 | 5.67% | 5,228,609 | $19.23 |
| 7 | 2023 - Q2 (2023-06-30) | $132,336,094 | 10.69% | 5,228,609 | $31.15 |
| 8 | 2023 - Q1 (2023-03-31) | $169,753,432 | 14.06% | 5,270,209 | $31.17 |
| 9 | 2022 - Q4 (2022-12-31) | $97,535,422 | 8.31% | 5,283,609 | $22.87 |
| 10 | 2022 - Q3 (2022-09-30) | $118,936,000 | 9.4% | 4,405,039 | $20.29 |
| 11 | 2022 - Q2 (2022-06-30) | $60,878,000 | 5.3% | 4,405,039 | $15.40 |
| 12 | 2022 - Q1 (2022-03-31) | $86,106,000 | 6.65% | 4,415,689 | $15.17 |
| 13 | 2021 - Q4 (2021-12-31) | $71,308,000 | 4.55% | 4,369,366 | $16.67 |
| 14 | 2021 - Q3 (2021-09-30) | $89,204,000 | 5.38% | 3,201,866 | $28.54 |
| 15 | 2021 - Q2 (2021-06-30) | $94,903,000 | 5.22% | 3,201,866 | $28.85 |
| 16 | 2021 - Q1 (2021-03-31) | $89,492,000 | 5.09% | 3,201,866 | $27.66 |
| 17 | 2020 - Q4 (2020-12-31) | $75,762,000 | 3.97% | 2,673,313 | $25.90 |
| 18 | 2020 - Q3 (2020-09-30) | $50,152,000 | 2.75% | 1,994,905 | $26.22 |
| 19 | 2020 - Q2 (2020-06-30) | $41,621,000 | 2.49% | 1,704,372 | $19.74 |
| 20 | 2020 - Q1 (2020-03-31) | $9,112,000 | 0.76% | 615,705 | $20.68 |
| 21 | 2019 - Q4 (2019-12-31) | $1,438,000 | 0.07% | 88,590 | $15.51 |
| 22 | 2014 - Q4 (2014-12-31) | $0 | 0% | 0 | $17.47 |
| 23 | 2014 - Q3 (2014-09-30) | $1,554,000 | 0.11% | 80,369 | $26.06 |
| 24 | 2014 - Q2 (2014-06-30) | $3,117,000 | 0.23% | 91,669 | $31.34 |
| 25 | 2014 - Q1 (2014-03-31) | $2,888,000 | 0.23% | 91,669 | $31.24 |
The displayed share prices are average quarterly stock market prices.